A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant
NCT05997459
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Locally Advanced Unresectable Gastric Cancer
Interventions
DRUG:
Pemigatinib
Sponsor
Sun Yat-sen University